@babfitz Here you have justification for the use of ARBS in severe cases. Besides they have had great candidates to battle with covid, they ve learned a lot from sars cov1 . We are in the second half of 2021 and still no progress. https://t.co/5wqL6z4kud,
RT @just_me_mac: Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortali…
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research https://t.co/lNUhcu7Ren
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research https://t.co/NAFvkHOeLQ
Congratulations! @CircRes Population Science paper of 2020 goes to Zhang, et al from the June 5th issue showing use of #ACE inhibitors/ARBs is not associated with increased mortality compared to nonusers in #COVID19 patients with hypertension https://t.co/
RT @CircRes: ICYMI: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that us…
RT @trishgreenhalgh: ACE inhibitors and Angiotensin Receptor blockers do not appear to be associated with increased mortality in covid-19 p…
Çin çalışması ACE inhibitörü/ARB kullanan hipertansiyonlu covid19 hastalarında mortalite daha düşük bulunmuş https://t.co/04lvtRFvk7
#ACE2Inhibitors seems to increase life expectancy in #COVID19 patients with hypertension. #COVID attacks the ACE2 receptors on cells to get inside. https://t.co/TWXMasBsBG
Not sure too many things have moved Covid mortality over 5%. Interesting to see if it works without chronic pre-treatment. Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors With Mortality Among Covid Patients | Circulation Research
RT @CircRes: ICYMI: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that us…
RT @CircRes: ICYMI: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that us…
RT @CircRes: ICYMI: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that us…
RT @CircRes: ICYMI: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that us…
RT @CircRes: ICYMI: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that us…
RT @CircRes: ICYMI: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that us…
RT @CircRes: ICYMI: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that us…
RT @CircRes: ICYMI: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that us…
ICYMI: Are ACE/ARB inhibitors safe for #COVID19 patients? https://t.co/FGsCthPS24 A new observational study suggests that use of #ACE inhibitors/ARBs is not associated with increased mortality compared to nonusers with hypertension. #AHACOVD19 https://t.
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research https://t.co/QAGQN9zYvh
RT @doc_Moreno: Veníamos avisando -> Si tu hipertensión esta bien controlada, no cambies la medicación por el COVID y las teorías de IECA/A…
@rwyeh @drjohnm @gorskon @_MiguelHernan @mikejohansenmd @raj_mehta @metrics52 On a slight, but only slight, tangent, some observational nostalgia https://t.co/CZ95aSKFpd
RT @headachedoc: If you’re considering which #migraine preventive start for your patient, it might be time for candesartan or lisinopril.…
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research https://t.co/3chlZl0PVN
@EricTopol @Bob_Wachter @UCSF @Novartis I'm still cautiously optimistic regarding these ARB and ACEi trials https://t.co/LIXoEYzlHr Targets the relevant viral pathway, and seems to have promising early data : https://t.co/WpBiYCLS3E Fingers are crossed!
@ChrisMasterjohn @ScottAdamsSays @kristina_basham If there is a U-shape response for Vit. D, why was the mean for severe/critical so low? Especially in sun-drenched SE Asia, where average D levels are surely higher? Up-regulation of ACE2 in smokers and ACE
I am aware of 4 observational studies that showed no ass btw @ACEIs use and risk of #COVID19 infection/mortality. @NEJM @JAMACardio @CircAHA 1. https://t.co/Dd2cx7iGGT 2. https://t.co/73E8VxeeXM 3. https://t.co/MQReHOdWzi 4. https://t.co/WDw0Gj2KPl Do y
RT @MiriamETucker: Still not the final word, but for sure anyone already prescribed and taking blood pressure drugs ACEIs (generic names en…
@MFrank_44 @RobertLKruse Observational studies so far point in direction of no effect on mortality rates. Examples: https://t.co/LXHZUvGP2q https://t.co/VqPlO0qUHz For a full overview: https://t.co/1CWMI3Udvs
RT @HIMMELHIMMEL: Never jump to conclusions too quickly. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angio…
Never jump to conclusions too quickly. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research https://t
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. Revisión de https://t.co/3SJvifbqZ3 en https://t.co/nDDP69WGAo #IECAs #ARAs #COVID19 #COVID19SEMERGEN https://t.co/H5e2aEBqpH
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research https://t.co/jC7TCtS4Nu
@faheyc3 Observation data, but a very good start. https://t.co/IYhPvKVO5P https://t.co/lyCl3Qu7Jn
RT @DrRickLanman: In NEJM three studies support the Chinese study I tweeted on below. No association of ACE inhibitors (ACEi) or ARBs, used…
No increased risk of mortality with ARB/ACEI’s in COVID patients #covid https://t.co/1hmgpHnfew
RT @DrLoomba: Association of Inpatient Use of ACE Inhibitors and ARB with Mortality .....COVID-19 | Circulation Research https://t.co/90Cl8…
RT @FZores: Traitement par IEC et ARA2 et risque de forme sévère et/ou d'infection COVID19. On en parle depuis 6 semaines environs. Il y a…
RT @FZores: Traitement par IEC et ARA2 et risque de forme sévère et/ou d'infection COVID19. On en parle depuis 6 semaines environs. Il y a…
RT @FZores: Traitement par IEC et ARA2 et risque de forme sévère et/ou d'infection COVID19. On en parle depuis 6 semaines environs. Il y a…
Traitement par IEC et ARA2 et risque de forme sévère et/ou d'infection COVID19. On en parle depuis 6 semaines environs. Il y a 10 jours une étude rétrospective se révélait rassurante avec toutes les limites que l'on peut attendre 🔜 https://t.co/36hyftxD
@MiriamETucker @EricTopol @NEJM Also this article in @CircRes from Wuhan suggested benefit - lower all-cause mortality in those on ACEI/ARB. https://t.co/CfH3lPGgJ2
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
In NEJM three studies support the Chinese study I tweeted on below. No association of ACE inhibitors (ACEi) or ARBs, used for hypertension, wtih increased COVID-19 mortality. One of the 3 new studies also found possible lower risk on ACEi/ARB. https://t.co
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. Revisión de https://t.co/3SJvifbqZ3 en https://t.co/nDDP69WGAo #IECAs #ARAs #COVID19 #COVID19SEMERGEN https://t.co/b9zsPebXtb
Decrease mortality in hospitalized patients who were on ACE/ARB therapy compared to those patients not on ACE/ARB therapy. https://t.co/I8dK6Q8aC2
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @doc_Moreno: Veníamos avisando -> Si tu hipertensión esta bien controlada, no cambies la medicación por el COVID y las teorías de IECA/A…
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research https://t.co/ZUfyYxN3W2
The data for inhibiting RAS with ACE1/ARBs look better and better everyday for #COVID19. 58% reduction in mortality in hypertensive hospitalized COVID19 patients with ACEI/ARBs https://t.co/sE8wSgZ6AA
RT @DrRickLanman: Antihypertensive ACE/ARB treatment associated with LOWER COVID-19 mortality in Chinese study. Published in Circulation Re…
ARB/ACEI処方されている人が多いからかも…。 https://t.co/EVdkLLs3vQ
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @probstMD: Two studies looking at ACEi/ARB effect on patients with #COVID19 from Hubei. 1⃣ From @JAMACardio ➡️no association with wors…
No obstante, un estudio retrospectivo realizado en 1128 pacientes con #Covid_19 (de los cuales 188 tomaban los medicamentos), mostró de forma inesperada que los pacientes que toman estos medicamentos presentaban un menor riesgo de muerte (https://t.co/I8Fp
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
Antihypertensive ACE/ARB treatment associated with LOWER COVID-19 mortality in Chinese study. Published in Circulation Research. Hypertensives hospitalized with COVID-19 had higher mortality if not on ACE/ARB medication. @natefavini https://t.co/wKOr31VT0
RT @probstMD: Two studies looking at ACEi/ARB effect on patients with #COVID19 from Hubei. 1⃣ From @JAMACardio ➡️no association with wors…
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research https://t.co/riCNfOVb0E
Continuando con HAS y el tratamiento con IECA/ARA II en pacientes infectados con COVID-19... Circulation publicó un artículo sobre el tto con IECA/ARA II en pacientes hospitalizados infectados por COVID-19 y su asociación a mortalidad. https://t.co/6vUsS5
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 | Circulation Research https://t.co/ye0H4SfTz3
Again about ACEi/ARB and #COVID19. This study shows that, among hospitalized #Covid_19 patients with hypertension, inpatient use of ACEI/ARB is associated with lower risk of all-cause mortality. https://t.co/WYeog7j5mz
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
RT @SEMERGENap: Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. R…
Los pacientes hipertensos hospitalizados por #COVID19, en tratamiento con #IECAs o #ARAs, parecen tener menos mortalidad. Revisión de https://t.co/3SJvifbqZ3 en https://t.co/nDDP69WGAo #IECAs #ARAs #COVID19 #COVID19SEMERGEN https://t.co/RMh6dNd7dD
RT @ABsteward: Surprising! @CircRes @CircAHA Among hospitalized COVID-19 patients with hypertension, inpatient use of ACEI/ARB was associat…
This was a welcome study for the millions of people with HTN who take these drugs every day. The ACC correctly advised continued use of these drugs early on, even before the results of this study were released.
Two studies looking at ACEi/ARB effect on patients with #COVID19 from Hubei. 1⃣ From @JAMACardio ➡️no association with worse outcomes. https://t.co/YSys1PMzkO 2⃣ From @CircRes ➡️associated with *improved* outcomes. https://t.co/FcxCGeefHN KM-Curve of
Haven't read in detail myself yet. Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19 https://t.co/C4KuSzqJ4F
RT @doc_Moreno: Veníamos avisando -> Si tu hipertensión esta bien controlada, no cambies la medicación por el COVID y las teorías de IECA/A…
RT @doc_Moreno: Veníamos avisando -> Si tu hipertensión esta bien controlada, no cambies la medicación por el COVID y las teorías de IECA/A…
RT @doc_Moreno: Veníamos avisando -> Si tu hipertensión esta bien controlada, no cambies la medicación por el COVID y las teorías de IECA/A…
RT @doc_Moreno: Veníamos avisando -> Si tu hipertensión esta bien controlada, no cambies la medicación por el COVID y las teorías de IECA/A…
RT @urenacard: Menor mortalidad con uso de BRAs o IECAs Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angio…
RT @toyosh: 臨床的には、みんな気になってる、高血圧患者に対してのACE阻害薬・ARBの使用がCOVIDの転帰を悪化させるのかどうか。 Circulation researchに出た論文の結論は、むしろ死亡率を下げる！！交絡因子とかは考えないといけないけど、少なくとも…
RT @toyosh: 臨床的には、みんな気になってる、高血圧患者に対してのACE阻害薬・ARBの使用がCOVIDの転帰を悪化させるのかどうか。 Circulation researchに出た論文の結論は、むしろ死亡率を下げる！！交絡因子とかは考えないといけないけど、少なくとも…
RT @toyosh: 臨床的には、みんな気になってる、高血圧患者に対してのACE阻害薬・ARBの使用がCOVIDの転帰を悪化させるのかどうか。 Circulation researchに出た論文の結論は、むしろ死亡率を下げる！！交絡因子とかは考えないといけないけど、少なくとも…
Clinically, we're all wondering if the use of ACE inhibitors/ARBs in hypertensive patients worsens #COVID19 outcomes. A paper from Circulation Research concluded that it rather lowers the mortality rate!!! https://t.co/b9768qz9ya
臨床的には、みんな気になってる、高血圧患者に対してのACE阻害薬・ARBの使用がCOVIDの転帰を悪化させるのかどうか。 Circulation researchに出た論文の結論は、むしろ死亡率を下げる！！交絡因子とかは考えないといけないけど、少なくとも死亡率を上げるわけじゃないんだ。 https://t.co/b9768qz9ya